Approximation to the Consumption of Healthcare Resources and the Economic Cost of Sars-CoV-2 Patient Management
A Retrospective Study
Datos Bibliográficos
| ID | 22069554 |
|---|---|
| Autores | M R da Silva (autor de correspondencia), Jesús Calderón-Moreno, Raul Juarez-Vela (0000-0003-3597-2048), Manuel J Díaz Rodríguez (0000-0003-3830-2701), Manuel Quintana-Díaz, Rosa Magallón-Botaya (0000-0002-3006-5353), Bárbara Oliván-Blázquez, Ana Cobos-Rincón (0000-0002-4121-8992), Iván Santolalla‐Arnedo (0000-0001-6705-7122), Carmen Amaia Ramírez-Torres, Vicente Gea-Caballero (0000-0001-8607-3195), Eva María Andrés-Esteban |
| Año | 2022 |
| Volumen | 10 |
| Páginas | 843751-843751 |
| Fecha de publicación | 2022-03-31 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Frontiers in Public Health (JOURNAL) |
| Identificadores de la revista | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Editorial | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2022.843751 |
| OpenAlex | W35433597 |
| Idioma | EN |
| Citas recibidas | 1 |
| Referencias citadas | 8 |
Spain has become one of the countries most affected by coronavirus disease 2019 (COVID-19), with the highest testing rates, and one of the worst-performing countries in the fight against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. There are no studies related to the consumption of health resources and the economic cost of the SARS-CoV-2 virus. We present a retrospective analysis of 9,811 (Primary Care and Hospital) patients which aimed to estimate public health expenditure by the consumption of health resources due to COVID-19. According to the results, the gender distribution of patients has a similar rate in both groups, with slightly higher rates in women. Similarly, age is the same in both groups, with a median of 62 years in the case of hospitalizations and 61 years in the case of primary care; using a weighted average of these rates and costs, we can estimate that the average cost of care per patient infected with the SARS-CoV-2 virus, regardless of the course is €2373.24. We conclude that a patient with COVID-19 without hospitalization costs €729.79, while the expenses of a hospitalized patient are between €4294.36 and €14440.68, if there is ICU admission
Achatina · Biology · Propolis · Snail · Bee Products Chemical Analysis · Ecology · Food Science
| Obras citantes distintas | 1 |
|---|---|
| Citas por año | 0,5 |
| Intervalo de citas | 2024 - 2024 (1) |
| Velocidad de citación | recent |
| Altamente citado | No |
| Tipos de cita | Neutras: 1 |